816 results on '"Paulus, Walter J."'
Search Results
2. Heart failure with preserved ejection fraction
3. Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
4. Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases.
5. Diastolic dysfunction is initiated by cardiomyocyte impairment ahead of endothelial dysfunction due to increased oxidative stress and inflammation in an experimental prediabetes model
6. Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin
7. Geranylgeranylacetone reduces cardiomyocyte stiffness and attenuates diastolic dysfunction in a rat model of cardiometabolic syndrome
8. Paving the Road for Interleukin-6 Inhibition in Heart Failure With Preserved Ejection Fraction
9. Myocardial stress and hypertrophy: a complex interface between biophysics and cardiac remodeling
10. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction
11. Effects of tDCS on motor learning and memory formation: A consensus and critical position paper
12. Sex differences in circulating proteins in heart failure with preserved ejection fraction
13. Nitric Oxide and Cardiac Contraction: Clinical Studies
14. Alterations in Ventricular Function
15. Contributors
16. Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction
17. p47phox-Dependent Reactive Oxygen Species Stimulate Nuclear Translocation of the FoxO1 Transcription Factor During Metabolic Inhibition in Cardiomyoblasts
18. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
19. Ventricular myocarditis coincides with atrial myocarditis in patients
20. Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles
21. Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure With Preserved Ejection Fraction?
22. Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction
23. Phenotypic Persistence in Heart Failure With Preserved Ejection Fraction
24. Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
25. Atrial Fibrillation Coincides with the Advanced Glycation End Product Nε-(Carboxymethyl)Lysine in the Atrium
26. Heart failure with preserved ejection fraction: a nephrologist-directed primer
27. Ultrasound and Microbubble-Induced Local Delivery of MicroRNA-Based Therapeutics
28. Lymphocytes Infiltrate the Quadriceps Muscle in Lymphocytic Myocarditis Patients: A Potential New Diagnostic Tool
29. Low-grade inflammation and endothelial dysfunction explain the association between retinopathy and left ventricular ejection fraction in men: an 8-year follow-up of the Hoorn Study
30. Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of H9c2 cells
31. H2FPEF Score: At Last, a Properly Validated Diagnostic Algorithm for Heart Failure With Preserved Ejection Fraction
32. Coronary Artery Disease and Diastolic Left Ventricular Dysfunction
33. Invasive Evaluation of Diastolic Left Ventricular Dysfunction
34. Myocardial Contractile Effects of Nitric Oxide
35. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology
36. The Role of Nitric Oxide in the Failing Heart
37. Abstract 14800: Limited Accuracy of the New ASE/EACVI-Algorithm for Heart Failure With Preserved Ejection Fraction (VeeDIA-Study I)
38. α-B Crystallin Reverses High Diastolic Stiffness of Failing Human Cardiomyocytes
39. Phosphodiesterase‐5 inhibition in heart failure with preserved ejection fraction: trading therapy for prevention
40. Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
41. Border Disputes Between Heart Failure Phenotypes
42. Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life
43. Increased cardiovascular risk 9-16 years after early onset preeclampsia: 67
44. Higher prevalence of diastolic dysfunction in women who have had a decade ago early onset preeclampsia: 66
45. Intracoronary pressure measurements with a 0.015″ fluid-filled angioplasty guide wire
46. Comparative Effects of Ischemia and Hypoxemia on Left Ventricular Diastolic Function in Humans
47. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap
48. From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress
49. Failure of myocardial inactivation: a clinical assessment in the hypertrophied heart
50. Inhibition of Rho–ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.